In this CD4-independent HIV-1 infection, GalCer or other sphingolipids could act as co-factors to induce structural modifications of HIV-1 glycoprotein, thus catalyzing the interaction with CCR5 and promoting viral entry. The gene discussed is CD4; the disease is HIV-1 infection.